NCT05838703 - Tiotropium Handihaler vs. Tiotropium Respimat in COPD | Biotech Hunter

Timeline

Start Date

May 1, 2023

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

tiotropium bromide inhalation powder (Spiriva HandiHaler)

Spiriva HandiHaler is a COPD medication that is available for use.

DRUG

tiotropium bromide (Spiriva Respimat)

Spiriva Respimat is a COPD medication that is available for use.

DRUG

Hyperpolarized 129XeMRI

Xe129 hyperpolarized with use of MRI for evaluation of lung ventilation has recently been FDA approved